Dr. Muhammad Noman Khan

Assistant Professor
University of Karachi, Pakistan

Highest Degree
Ph.D. in Molecular Biology from Dalian Medical University, China

My URL
https://livedna.org/92.27760

Share this Profile

Area of Interest:

Biomedical Sciences
Molecualar Biology
Cancer Immunology
Glycobiology
Physiology

Selected Publications

  1. Wang, J., L. Tian, M.N. Khan, L. Zhang and Q. Chen et al., 2018. Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking NF-kB mediated Epithelial-Mesenchymal Transition (EMT) and stemness. Cancer Letters, 415: 73-85.
    CrossRef  |  Direct Link  |  

  2. Liu, C., X. Liang, J. Wang, Q. Zheng and Y. Zhao et al., 2017. Protein O-fucosyltransferase 1 promotes trophoblast cell proliferation through activation of MAPK and PI3K/Akt signaling pathways. Biomed. Pharmacother., 88: 95-101.
    CrossRef  |  Direct Link  |  

  3. Cui, S., Y. Zhu, J. Du, M.N. Khan and B. Wang et al., 2017. CXCL8 antagonist improves diabetic nephropathy in male mice of diabetes and attenuates high glucose-induced mesangial injury. Endocrinol., 158: 1671-1684.
    CrossRef  |  Direct Link  |  

  4. Chen, X., L. Li, M.N. Khan, L. Shi and Z. Wang et al., 2016. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production. Innate Immun., 22: 696-705.
    CrossRef  |  Direct Link  |  

  5. Lingyun, L., M.N. Khan, L. Qiang, C. Xiangyu and W. Jing et al., 2015. G31P, CXCR1/2 inhibitor with cisplatin inhibits growth of mice hepatocellular carcinoma and mitigates high dose cisplatin-induced nephrotoxicity. Oncol. Rep., 33: 751-757.
    CrossRef  |  Direct Link  |  

  6. Khan, M.N., B. Wang, J. Wei, Y. Zhang and Q. Li et al., 2015. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8 (3-72) K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Oncotarget., 6: 21315-21327.
    CrossRef  |  Direct Link  |  

  7. Wei, J., X. Chen, Q. Li, J. Chen and M.N. Khan et al., 2014. ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity. Oncol. Rep., 31: 1599-1604.
    CrossRef  |  Direct Link  |  

  8. Khan, M.N., T.A. Khan and Z. Ahmed, 2013. Discrepancy in ABO blood grouping. J. Coll. Physicians Surg. Pak., 23: 590-592.
    Direct Link  |  

  9. Khan, T.A., S.F. Rehmani, A. Ahmed, N.A. Lone and M.N. Khan, 2012. Characterization of Newcastle disease virus isolated during 1995-2009 from suburbs of Karachi-Pakistan. Pak. J. Zool., 44: 443-448.
    Direct Link  |  
Member since March, 2019